Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1Breast 1

Conditions

Glioblastoma 12Prostatic Neoplasms 11Breast Neoplasms 10Lung Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Neoplasm Metastasis 7Squamous Cell Carcinoma of Head and Neck 6Sarcoma 5Oropharyngeal Neoplasms 5Neoplasms 4Histiocytoma, Malignant Fibrous 4Head and Neck Neoplasms 4Brain Neoplasms 4Astrocytoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma, Synovial 3Rhabdomyosarcoma 3Melanoma 3Liposarcoma 3Leiomyosarcoma 3Hodgkin Disease 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Hepatocellular 3Adenocarcinoma Of Esophagus 3Stomach Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma, Alveolar 2

Interventions

avelumab 7Nivolumab 5pembrolizumab 4Specimen Handling 3Ipilimumab 3Biopsy 3cemiplimab 2atezolizumab 2Radiotherapy 2Magnetic Resonance Spectroscopy 2tocilizumab 1talimogene laherparepvec 1prednylidene 1poly ICLC 1lutetium Lu 177 dotatate 1lenvatinib 1fludarabine phosphate 1fludarabine 1flt3 ligand protein 1durvalumab 1deltacortene 1Tacrolimus 1Saline Solution 1Radiosurgery 1Radiation 1Prednisone 1MAPRE1 protein, human 1Lutetium-177 1Immunoglobulin G 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Merkel Cell × Radiation × Clear all
NCT04616248 2026-01-07

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

University of Southern California

Phase 1 Active not recruiting
14 enrolled
BreastDermatologicSarcoma

Bone Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Melanoma, Sarcoma, Osteosarcoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡